188 related articles for article (PubMed ID: 32735025)
1. Cutaneous Infantile Haemangiomas with Intracranial and Intraspinal Involvement: A European Multicentre Experience and Review.
Diociaiuti A; Carnevale C; Torres EB; Léauté-Labrèze C; Neri I; Rotunno R; Figà-Talamanca L; El Hachem M
Acta Derm Venereol; 2020 Sep; 100(16):adv00255. PubMed ID: 32735025
[TBL] [Abstract][Full Text] [Related]
2. Propranolol was effective in treating cutaneous infantile haemangiomas in Thai children.
Techasatian L; Komwilaisak P; Panombualert S; Uppala R; Jetsrisuparb C
Acta Paediatr; 2016 Jun; 105(6):e257-62. PubMed ID: 26919396
[TBL] [Abstract][Full Text] [Related]
3. Interventions for infantile haemangiomas of the skin.
Novoa M; Baselga E; Beltran S; Giraldo L; Shahbaz A; Pardo-Hernandez H; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD006545. PubMed ID: 29667726
[TBL] [Abstract][Full Text] [Related]
4. [Propranolol therapy for periocular and orbital infantile haemangiomas].
Sterker I; Tegetmeyer H; Sorge I; Weißer M; Böhm R
Klin Monbl Augenheilkd; 2014 Oct; 231(10):971-9. PubMed ID: 25333232
[TBL] [Abstract][Full Text] [Related]
5. Propranolol for infantile haemangiomas: single centre experience of 250 cases and proposed therapeutic protocol.
Solman L; Murabit A; Gnarra M; Harper JI; Syed SB; Glover M
Arch Dis Child; 2014 Dec; 99(12):1132-6. PubMed ID: 25123404
[TBL] [Abstract][Full Text] [Related]
6. Infantile haemangioma.
Léauté-Labrèze C; Harper JI; Hoeger PH
Lancet; 2017 Jul; 390(10089):85-94. PubMed ID: 28089471
[TBL] [Abstract][Full Text] [Related]
7. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.
Holmes WJ; Mishra A; Gorst C; Liew SH
J Plast Reconstr Aesthet Surg; 2011 Apr; 64(4):445-51. PubMed ID: 20797926
[TBL] [Abstract][Full Text] [Related]
8. Shouldn't Propranolol Be Used to Treat All Haemangiomas?
Moodley ST; Hudson DA; Adams S; Adams KG
Aesthetic Plast Surg; 2015 Dec; 39(6):963-7. PubMed ID: 26377820
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of infantile haemangiomas of the orbit with propranolol.
Li YC; McCahon E; Rowe NA; Martin PA; Wilcsek GA; Martin FJ
Clin Exp Ophthalmol; 2010 Aug; 38(6):554-9. PubMed ID: 20491798
[TBL] [Abstract][Full Text] [Related]
10. Infantile haemangiomas that failed treatment with propranolol: clinical and histopathological features.
Phillips RJ; Lokmic Z; Crock CM; Penington A
J Paediatr Child Health; 2014 Aug; 50(8):619-25. PubMed ID: 24905852
[TBL] [Abstract][Full Text] [Related]
11. Treatment of complex infantile haemangioma in a resource-poor setting.
Natawidjaja R; Wang E
BMJ Case Rep; 2014 Jul; 2014():. PubMed ID: 25053694
[TBL] [Abstract][Full Text] [Related]
12. Propranolol therapy for cutaneous infantile haemangiomas initiated safely as a day-case procedure.
McSwiney E; Murray D; Murphy M
Eur J Pediatr; 2014 Jan; 173(1):63-8. PubMed ID: 23933667
[TBL] [Abstract][Full Text] [Related]
13. Propranolol, infantile haemangiomas, and serendipity: new use for an old drug.
Grech V; Scerri C
Libyan J Med; 2011 Jan; 6(1):5826. PubMed ID: 28156195
[TBL] [Abstract][Full Text] [Related]
14. [Infantile haemangioma: clinical and demographic characteristics, experiences in the treatment].
Csoma ZR; Dalmády S; Ábrahám R; Rózsa T; Rácz K; Kemény L
Orv Hetil; 2017 Oct; 158(39):1535-1544. PubMed ID: 28942665
[TBL] [Abstract][Full Text] [Related]
15. Propranolol-resistant infantile haemangiomas.
Caussé S; Aubert H; Saint-Jean M; Puzenat E; Bursztejn AC; Eschard C; Mahé E; Maruani A; Mazereeuw-Hautier J; Dreyfus I; Miquel J; Chiaverini C; Boccara O; Hadj-Rabia S; Stalder JF; Barbarot S;
Br J Dermatol; 2013 Jul; 169(1):125-9. PubMed ID: 23659587
[TBL] [Abstract][Full Text] [Related]
16. A retrospective analysis of systemic propranolol for the treatment of complicated infantile haemangiomas.
Schneider M; Cremer HJ; Ruef P
Acta Paediatr; 2014 Sep; 103(9):977-83. PubMed ID: 24837972
[TBL] [Abstract][Full Text] [Related]
17. [Medical treatment of children with infantile haemangiomas].
Velure HK; Hartling UB; Schuster A; Bygum A
Ugeskr Laeger; 2017 Feb; 179(8):. PubMed ID: 28397661
[TBL] [Abstract][Full Text] [Related]
18. Use of propranolol for treatment of infantile haemangiomas in an outpatient setting.
Phillips RJ; Penington AJ; Bekhor PS; Crock CM
J Paediatr Child Health; 2012 Oct; 48(10):902-6. PubMed ID: 22897120
[TBL] [Abstract][Full Text] [Related]
19. Immediate possible adverse event rates in infants treated with oral propranolol for infantile haemangiomas at an Australian urban tertiary hospital between 2016 and 2019.
Adams L; Ryan E
Australas J Dermatol; 2022 Nov; 63(4):473-478. PubMed ID: 35938573
[TBL] [Abstract][Full Text] [Related]
20. Distribution of problematic localized facial infantile haemangiomas and their response to propranolol: a retrospective cohort study.
Chang L; Chen Q; Zhou L; Chang SJ; Gao W; Yu Z; Chen J; Li H; Qiu Y; Lin X
Clin Exp Dermatol; 2023 Mar; 48(3):193-198. PubMed ID: 36763678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]